900000000000509007: United States of America English language reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Language type reference set (foundation metadata concept)\English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)\US English

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
US English	Is a	English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	acceptabilityId
Product containing precisely aspirin 100 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely aspirin 120 milligram/1 each conventional release rectal suppository (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely aspirin 150 milligram/1 each conventional release rectal suppository (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely aspirin 150 milligram/1 each gastro-resistant oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely aspirin 165 milligram/1 each gastro-resistant oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely aspirin 300 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely aspirin 325 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely aspirin 325 milligram/1 each gastro-resistant oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely aspirin 500 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely aspirin 500 milligram/1 each gastro-resistant oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely atazanavir (as atazanavir sulfate) 100 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely atazanavir (as atazanavir sulfate) 300 milligram and ritonavir 100 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely atazanavir (as atazanavir sulfate) 300 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely atenolol 100 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely atenolol 25 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely atenolol 5 milligram/1 milliliter conventional release oral solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely atenolol 50 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely atorvastatin (as atorvastatin calcium) 10 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely atorvastatin (as atorvastatin calcium) 20 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely atorvastatin (as atorvastatin calcium) 40 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely atorvastatin (as atorvastatin calcium) 80 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely atracurium besilate 10 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely atropine sulfate 1 milligram/1 milliliter conventional release eye solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely atropine sulfate 1 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely atropine sulfate 10 milligram/1 milliliter conventional release eye drops (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely atropine sulfate 5 milligram/1 milliliter conventional release eye drops (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely avibactam (as avibactam sodium) 500 milligram and ceftazidime 2 gram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely azathioprine (as azathioprine sodium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely azathioprine 50 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely azithromycin 250 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely azithromycin 40 milligram/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely azithromycin 500 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely azithromycin dihydrate 15 milligram/1 gram conventional release eye drops (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely barium sulfate 1 milligram/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely barium sulfate 240 milligram/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely barium sulfate 49 milligram/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely barium sulfate 600 milligram/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely beclometasone dipropionate 250 microgram/1 actuation conventional release pressurized solution for inhalation (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely beclometasone dipropionate 50 microgram/1 actuation conventional release pressurized solution for inhalation (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely bedaquiline (as bedaquiline fumarate) 100 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely bendamustine hydrochloride 90 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely benzathine benzylpenicillin 1.2 million unit/1 vial powder for conventional release suspension for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely benzathine benzylpenicillin 2.4 million unit/1 vial powder for conventional release suspension for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely benznidazole 100 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely benznidazole 12.5 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely benznidazole 50 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely benzoyl peroxide 50 milligram/1 gram conventional release cutaneous cream (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely benzoyl peroxide 50 milligram/1 gram conventional release cutaneous lotion (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely benzyl benzoate 250 milligram/1 milliliter conventional release cutaneous emulsion (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely benzylpenicillin (as benzylpenicillin potassium) 5 million unit/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely benzylpenicillin sodium 600 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous cream (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous ointment (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely bevacizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely biperiden hydrochloride 2 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely biperiden lactate 5 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely bisoprolol fumarate 1.25 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely bisoprolol fumarate 5 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely bleomycin (as bleomycin sulfate) 15 unit/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely bortezomib 3.5 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely budesonide 100 microgram and formoterol fumarate dihydrate 6 microgram/1 actuation conventional release powder for inhalation (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely budesonide 100 microgram/1 actuation conventional release nasal spray (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely budesonide 100 microgram/1 actuation conventional release powder for inhalation (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely budesonide 200 microgram and formoterol fumarate dihydrate 6 microgram/1 actuation conventional release powder for inhalation (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely budesonide 200 microgram/1 actuation conventional release powder for inhalation (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely bupivacaine hydrochloride 2.5 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely bupivacaine hydrochloride 5 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 2 milligram/1 each conventional release sublingual tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 200 microgram/1 each conventional release sublingual tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 300 microgram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 400 microgram/1 each conventional release sublingual tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram/1 each conventional release sublingual tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely buprenorphine 10 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely buprenorphine 20 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely buprenorphine 35 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely buprenorphine 52.5 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely caffeine citrate 20 milligram/1 milliliter conventional release oral solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely caffeine citrate 20 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely calamine 150 milligram/1 milliliter and zinc oxide 50 milligram/1 milliliter conventional release cutaneous lotion (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely calcium carbonate 1.25 gram/1 each conventional release chewable tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely calcium carbonate 1.25 gram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely calcium chloride 270 microgram and potassium chloride 400 microgram and sodium chloride 6 milligram and sodium lactate 3.2 milligram/1 milliliter conventional release solution for infusion (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely calcium folinate 15 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely calcium folinate 5 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely calcium gluconate 100 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely capecitabine 150 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely capecitabine 500 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely carbamazepine 100 milligram/1 each conventional release chewable tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely carbamazepine 100 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely carbamazepine 20 milligram/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely carbamazepine 200 milligram/1 each conventional release chewable tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely carbamazepine 200 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely carbetocin 100 microgram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely carbimazole 20 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely carbimazole 5 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely carboplatin 10 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)

Start Previous Page 405 of 579 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001115012	United States of America English language reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	IPS terminology module (core metadata concept)
900000000001116013	US English	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	IPS terminology module (core metadata concept)
900000000001117016	United States of America English language reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	IPS terminology module (core metadata concept)